Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment

E-ISSN： 2212-3970|2|1|79-101

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.2, Iss.1, 2007-01, pp. : 79-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy

By Baguley Bruce C McKeage Mark J

Future Oncology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1537-1543

Future Medicine

Access to resources Recommend Favorite

The role of new agents in the treatment of non-small cell lung cancer

By Broker L.E. Giaccone G.

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2347-2361

Elsevier

Access to resources Recommend Favorite

Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 20-30

Bentham Science Publishers

Access to resources Recommend Favorite

Actual and Potential Agents and Biomarkers in the Treatment of Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 500-516

Bentham Science Publishers

Access to resources Recommend Favorite

Potential New Agents for Chronic Lymphocytic Leukemia Treatment

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-11 ,pp. : 666-682

Bentham Science Publishers

Access to resources Recommend Favorite